Tag: PRIMA

2 articles

Market Moves

Science Corp Raises $230 Million to Commercialise PRIMA Retinal Implant

Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.

Mar 6

Market Moves

Science Corporation Raises $230M for PRIMA Retinal Implant

Max Hodak's Science Corporation secured $230 million in Series C funding to commercialize PRIMA, a photovoltaic retinal implant restoring vision for geographic atrophy patients.

Mar 6

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. Unsubscribe anytime. We respect your privacy.